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Abstract
In recent years, disorders of connective tissue metabolism that are involved in the pathogenesis of many diseases
have attracted increasing attention. They are of particular importance in the presence of connective tissue
dysplasia. Undifferentiated forms, being a frequent component of comorbid pathology, are quite widespread
among the general population. Among comorbidities, arterial hypertension, diabetes mellitus and undifferentiated
connective tissue dysplasia in various combinations are more often observed.
The objective of the research was to determine the prognostic significance of undifferentiated connective
tissue dysplasia in the development of arterial hypertension in the patients with type 2 diabetes mellitus.
Materials and methods. To determine the prognostic significance of undifferentiated connective tissue dysplasia
in the development of arterial hypertension, there was conducted an analysis of hospital discharge reports
received by the patients with type 2 diabetes mellitus duration of at least 2 years who were treated two to five
years ago. The predictive significance of the factors selected for the analysis was determined through applying
the regression analysis using a logistic regression model, the Wald test.
Results. The test for coincidence of the predicted and observed values revealed that the specificity of the
regression model was 87.2%, while its sensitivity was 89.7%. The overall predictability was 88.5%.
Conclusions. These are quite high indicators that allow us to apply the proposed model to detect the patients
with type 2 diabetes mellitus being at high risk of arterial hypertension.
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Problem statement and analysis of
the latest research
Connective tissue dysplasia (CTD) is a relatively
common pathology, that co-exists with other dis-
eases, especially cardiovascular ones. CTD is a
combination of genetically determined (congenital)
and acquired diseases in the presence of genetic
predisposition, namely dysplastic phenotypes (un-
differentiated CTD). A common feature of the dis-
eases included in the CTD dysplastic phenotypes is
a disruption of connective tissue metabolism with
corresponding changes in its components [2, 4]. In
case of pathology, as a result of pathological ac-
tivation or inhibition of the activity of connective
tissue cellular elements and changes in the structure
of the main substance, the disorders of connective
tissue metabolism may be the basis for the progres-
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sion of the pathological process, the development of
its complications and the appearance of comorbid
pathology [1, 3, 7, 8, 9].
The prevalence of CTD among the population
is quite high (within 2-7%), and the frequency of
single phenotypic symptoms reaches 24.3% [2, 4,
5, 6].
The co-existence of CTD, including its dysplas-
tic phenotypes, affects the clinical course of arterial
hypertension (AH) and diabetes mellitus (DM) as
well, and may result in the progression of these dis-
eases and the development of complications. Thus,
the presence of CTD in the patients with DM was
found to contribute to the increase in the incidence
of diabetic foot (40.7% and 5.7% in the control
group) and diabetic neuropathy (95% and 18.2%
in the control group); the development of arrhyth-
mias, psycho-emotional disorders and myocardial
damage [5, 6]; AH development in the patients with
neurocirculatory dystonia [2, 4]. In the patients with
DM and signs of CTD, an increase in vasopressor
activity and aggregation of platelets was observed.
The authors regarded it as a possible mechanism of
developing diabetic angiopathy [2, 5, 6].
Thus, the phenomenon of comorbidity can be
currently considered as a characteristic feature of
modern pathology, the incidence of which increases
with the patients’ age. Among comorbidities, AH,
DM and CTD in different combinations are the
most prevalent ones. These diseases are character-
ized by the development of various cardiovascular
complications that indicates the possible unity of
the pathogenetic mechanisms of their development.
Their study is relevant both in terms of the prog-
nosis of their clinical course and in the terms of
the identification of potential common therapeutic
targets.
The objective of the research was to deter-
mine the prognostic significance of undifferentiated
connective tissue dysplasia (UCTD) in the develop-
ment of AH in the patients with type 2 DM.
1. Materials and Methods
The study was carried out in the endocrinological
department of the Kharkiv Regional Clinical Hospi-
tal. The study included 90 patients with type 2 DM
at the age of 35-45 years who were treated during
2016-2018; disease duration was no more than 10
years.
All the patients underwent a complete physi-
cal, laboratory, and instrumental examinations ac-
cording to the Order of the Ministry of Health of
Ukraine dated 21.12.2012 No 1118 ”A Unified Clin-
ical Protocol for Primary and Secondary (Special-
ized) Medical Care. Type 2 Diabetes Mellitus.”
Diagnosis of AH was made in accordance with the
Order of the Ministry of Health of Ukraine No 384
dated 24.05.2012 ”Arterial Hypertension: An Up-
dated and Adapted Clinical Invention Based on Ev-
idence.” Diagnosis of UCTD was made through a
comprehensive examination considering the pres-
ence of its most prominent phenotypic manifesta-
tions, namely skeletal (chest deformity, scoliosis,
kyphosis, cranial deformation, joint hypermobil-
ity, dislocation/subluxation of any joint, flat feet,
arachnodactyly) and/or visceral ones (cardiovascu-
lar – valve prolapse, interatrial septal aneurysm,
additional chords, aortic root enlargement, tortu-
ous arteries, varicose veins, varicocele; digestive
- pathological reflux, gastroptosis, coloptosis, pto-
sis and/or deformed gallbladder, diverticula; renal -
nephroptosis, atony of pelvicalyceal system) [2].
To determine the prognostic significance of UCTD
in the development of AH, there was conducted an
analysis of hospital discharge reports received by
the patients with type 2 diabetes mellitus duration
of at least 2 years who were treated two to five years
ago. Such discharge reports were available in 78
patients. During the analysis, the attention was paid
to the presence of AH during the previous hospital-
izations, AH degree, the presence of the diseases
specific to UCTD during the last hospitalization.
To analyse the possibility of using UCTD signs
as predictors of AH development, the Wald test for
binary logistic regression (BLR) was applied. The
patients included in this analysis were divided into
two groups:
• Group I included 38 patients with type 2 DM
whose AH was not diagnosed during the pre-
vious hospitalizations and was not detected
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during the last hospitalization, and those who
did not differ in the degree of AH during the
previous and last hospitalizations;
• Group II included 40 patients with type 2 DM
whose AH was not diagnosed during the pre-
vious hospitalizations; however, during last
hospitalization, AH was detected, and those
whose AH degree increased during the last
hospitalization as compared to the previous
one.
Groups were encoded in the ordinal scale: Group I
– ”0”; Group II – ”1”.
Two indicators were introduced in the logistics
analysis:
• presence of UCTD signs; encoded as a sum of
individual visceral and/or skeletal symptoms
- x1.
• duration of type 2 DM in years - x2. This
indicator was introduced due to the known
effect of the duration of DM in the patients
with type 2 DM regardless of other indicators
as confirmed in our study as well.
2. Results and Discussion
The results of the analysis using BLR are presented
in Table 1. All regression coefficients of the in-
dicators included in the equation were reliable as
evidenced by the significance value<0.05 for all
the indicators and constant, while the significance
of the regression coefficient of UCTD was very
high<0.001 being significantly higher than in DM
duration. This indicated a rather high prognostic
value of UCTD in predicting the development of
AH.
The data obtained allowed us to calculate the z
value as follows:
z= x1×2.970+ x2×0.470+(−4.520) (1)
Then, the probability of AH development or pro-
gression was calculated by the following formula:
P=
1
1+ e(−z)
(2)
Table 1. Results of the regression analysis of AH
development or progression in the patients with
type 2 DM.
Indicator B S.E.
Wald
statis-
tics
Sign. (p)
x1 2.970 0.689 18.578 0.000
x2 0.470 0.204 5.320 0.021
Constant -4.520 1.367 10.927 0.001
Notes: x1 - signs of UCTD; x2 - duration of type 2 DM;
B - coefficient of regression B; S.E. – standard error of
the regression coefficient; p - level of significance of the
regression coefficient.
As a result of the analysis, both factors, namely
the presence of UCTD signs with a coefficient of
2.970 (p<0.001), and the duration of type 2 DM
– with a coefficient of 0.470 (p<0.021) were in-
cluded in the final equation for determining the
coefficient z. This was an evidence of the direct
effect of UCTD on the development of AH, and the
greater significance of this factor as compared to
the duration of type 2 DM.
The greater the final value of P, the greater prob-
ability of AH occurrence or its progression in the
patients with type 2 DM. The critical value, that
determines the patient at a risk of AH, is 0.5.
Table 2. Classification of the observed and
predicted values.
Observed value
Predicted value
AH development
Per-
centage
of
0 1
correct
predic-
tions
AH
development
0 34 4 89.5
1 5 35 87.5
Total percentage 88.5
Note: distinguishing value = 0.500
The data obtained indicated that the prediction
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of the negative result was 89.5%, the prediction of
the positive result was 87.5%, the overall prediction
was 88.5%.
Among 39 patients without AH development
or progression, correct prediction was obtained in
34 (87.2%) cases, indicating the specificity of BLR
equation. Among 39 patients with AH or AH pro-
gression, correct prediction was obtained in 35
(89.7%) cases, indicating the sensitivity of BLR
equation.
3. Conclusions
Rather high values of predictability, specificity and
sensitivity suggest the possibility of using this method
to predict the onset or progression of AH in the pa-
tients with type 2 DM. The data obtained will allow
identifying the patients requiring active methods of
AH prevention, even in the absence of other cardio-
vascular risks.
4. Prospects of Further
Researches
However, it should be noted that the study has cer-
tain limitations, namely, a limited age group (35-45
years), the retrospective nature of the analysis, the
absence of daily blood pressure monitoring in most
cases, variability of the analysis depth. At the same
time, these restrictions determine the prospects for
further research in this direction. It is advisable to
carry out a larger-scale study without age restric-
tions, using modern methods of objectifying blood
pressure fluctuations during the day, a long-term
study with the determination of the control points
of data collection, as well as the identification of
the most objective UCTD markers.
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